Chimeric Antigen Receptor T-cell Therapy
Summary
Chimeric Antigen Receptor T-cell Therapy; Prohibiting health insurers and health maintenance organizations issuing, delivering, or renewing certain policies or contracts from refusing to contract with or denying coverage for certain providers of chimeric antigen receptor T-cell therapy, etc.
Bill status
died
1 of 4 stages cleared
Introduction
Mar 2025
Committee Review
Floor Vote
Governor
Introduced Mar 4, 2025
Last action Jun 16, 2025
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
5
Key actions
0
Committee
1
Mar 4, 2025
Introduced
Introduced
upper
Feb 28, 2025
Committee
Referred to Banking and Insurance; Judiciary; Rules
upper
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Lori Berman
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about SB 876
Scope: FL
Hi! I can help you understand SB 876. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline